Simcere’s Sanbexin Sublingual Tablets Added to China’s 2026 Reimbursement ListTip Ranks·Nov 15, 2026 at 11:13 PM02096-0.76%
SSY Group Wins China Approval for Bicarbonate Peritoneal Dialysis SolutionPUBT·Nov 13, 2026 at 04:02 AM02005+0.58%
ZHEJIANG ZHENYUAN: On April 16, the company received a 'Notice of Custody' and a 'Notice of Case Filing' from the supervisory authority. Wei Min, a director and deputy general manager of the company, has been subjected to investigation and custody measuresWallstreetcn·Apr 17, 2026 at 12:55 PM000705-0.65%
ZHEJIANG ZHENYUAN terminates the issuance of stocks to specific objects and withdraws the application documentsZhitong·Oct 21, 2025 at 10:07 AM000705-0.65%
ZHEJIANG ZHENYUAN: The S1 production line is scheduled to officially start production at the end of AugustZhitong·Aug 27, 2025 at 07:26 AM000705-0.65%
ZHEJIANG ZHENYUAN: The synthetic biology project of Zhenyuan Bio is expected to be put into production in the third quarterZhitong·Jul 30, 2025 at 01:07 AM000705-0.65%
The synthetic biology concept strengthens, ALK hits the limit upZhitong·Jul 17, 2025 at 02:20 AM002940-3.36%000705-0.65%
Pharmaceutical stocks continued to rise in the afternoon, with LIVZON GROUP and nearly ten other stocks hitting the daily limitZhitong·Jul 16, 2025 at 06:11 AM002900-0.40%000513+0.66%
ZHEJIANG ZHENYUAN stated on the interactive platform that the innovative new drug for cancer pain treatment is still in the exploratory research stage and there are no plans for market launch at this timeZhitong·Jul 16, 2025 at 01:10 AM000705-0.65%
The pharmaceutical commercial sector has seen a short-term decline, with NO.1 PHARMACY dropping over 6%Zhitong·May 28, 2025 at 01:35 AM000705-0.65%301017-4.23%
The pharmaceutical commercial sector has seen a short-term surge, with YIXINTANG hitting the limit upZhitong·May 21, 2025 at 01:32 AM000411-0.31%000705-0.65%
ZHEJIANG ZHENYUAN: Chai Jun resigned as vice chairman and general manager due to job transferZhitong·Mar 28, 2025 at 08:54 AM000705-0.65%
ZHEJIANG ZHENYUAN: The synthetic biology project is currently progressing as planned, with the aim to be completed and put into production as soon as possible in 2025Finet HK·Feb 6, 2025 at 07:27 AM000705-0.65%
ZHEJIANG ZHENYUAN: Expected net profit in 2024 to decline by 55.2%-68% year-on-yearZhitong·Jan 17, 2025 at 12:55 PM000705-0.65%